Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash $ 23,798,343 $ 1,232,030
Other current asset 1,728,539
Prepaid expense 70,775 788
Total current assets 25,597,657 1,232,030
Property and equipment, net 15,377 8,758
Deferred offering costs 191,000
TOTAL ASSETS 25,613,034 1,432,576
CURRENT LIABILITIES    
Accounts payable and accrued expenses 467,988 489,292
Insurance payable 1,705,846  
Note payable 102,831
Total current liabilities 2,276,665 489,292
Loan payable 108,500
TOTAL LIABILITIES 2,385,165 489,292
COMMITMENTS AND CONTINGENCIES (NOTE 4)
STOCKHOLDERS' EQUITY    
Preferred Stock - Par Value (1,000,000 authorized at June 30, 2020; 3,480,000 authorized at December 31, 2019; $.0001 par value) (Zero shares issued and outstanding at June 30, 2020; 2,438,866 shares issued and outstanding at December 31, 2019) 244
Common Stock – Par Value (25,000,000 authorized at June 30, 2020; 12,180,000 authorized at December 31, 2019; $.0001 par value) (6,217,577 shares issued and outstanding at June 30, 2020; 1,978,269 shares issued and outstanding at December 31, 2019) 622 198
Additional paid-in capital 31,289,650 7,694,547
Accumulated deficit (8,062,403) (6,751,705)
Total stockholders' equity 23,227,869 943,284
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 25,613,034 $ 1,432,576